These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7587009)

  • 21. Prevalence of treated diabetes: Geographical variations at the small-area level and their association with area-level characteristics. A multilevel analysis in Southeastern France.
    Bocquier A; Cortaredona S; Nauleau S; Jardin M; Verger P
    Diabetes Metab; 2011 Feb; 37(1):39-46. PubMed ID: 20980182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies.
    Maier W; Holle R; Hunger M; Peters A; Meisinger C; Greiser KH; Kluttig A; Völzke H; Schipf S; Moebus S; Bokhof B; Berger K; Mueller G; Rathmann W; Tamayo T; Mielck A;
    Diabet Med; 2013 Mar; 30(3):e78-86. PubMed ID: 23127142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social disadvantage, family composition, and diabetes mellitus: prevalence and outcome.
    Baumer JH; Hunt LP; Shield JP
    Arch Dis Child; 1998 Nov; 79(5):427-30. PubMed ID: 10193257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes prevalence, process of care and outcomes in relation to practice size, caseload and deprivation: national cross-sectional study in primary care.
    Millett C; Car J; Eldred D; Khunti K; Mainous AG; Majeed A
    J R Soc Med; 2007 Jun; 100(6):275-83. PubMed ID: 17541098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed?
    Ledermann HM
    Diabetologia; 1995 Dec; 38(12):1482. PubMed ID: 8786024
    [No Abstract]   [Full Text] [Related]  

  • 27. The North Jutland County Diabetic Retinopathy Study: population characteristics.
    Knudsen LL; Lervang HH; Lundbye-Christensen S; Gorst-Rasmussen A
    Br J Ophthalmol; 2006 Nov; 90(11):1404-9. PubMed ID: 16825278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis.
    Harvey JN; Craney L; Kelly D
    J Epidemiol Community Health; 2002 Jan; 56(1):18-23. PubMed ID: 11801615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socioeconomic deprivation, coronary heart disease prevalence and quality of care: a practice-level analysis in Rotherham using data from the new UK general practitioner Quality and Outcomes Framework.
    Strong M; Maheswaran R; Radford J
    J Public Health (Oxf); 2006 Mar; 28(1):39-42. PubMed ID: 16436452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of general practice workload from census based social deprivation scores.
    Ben-Shlomo Y; White I; McKeigue PM
    J Epidemiol Community Health; 1992 Oct; 46(5):532-6. PubMed ID: 1479326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years.
    Low L; Law JP; Hodson J; McAlpine R; O'Colmain U; MacEwen C
    BMJ Open; 2015 Apr; 5(4):e007290. PubMed ID: 25877277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why don't all general practices offer structured diabetes care? A comparison of practices that do not with those that do.
    Goyder EC; Jennings S; Botha JL
    Public Health; 1996 Nov; 110(6):357-60. PubMed ID: 8979752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative treatment of patients with Diabetes mellitus].
    Ley SC; Preckel B; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):230-46; quiz 247-9. PubMed ID: 15832243
    [No Abstract]   [Full Text] [Related]  

  • 34. [Not Available].
    Minder A
    Ther Umsch; 2017; 74(8):441-444. PubMed ID: 29461150
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
    Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E
    Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes in children and adolescents.
    Chowdhury S; Sengupta N
    J Indian Med Assoc; 2008 Nov; 106(11):706-7. PubMed ID: 19368093
    [No Abstract]   [Full Text] [Related]  

  • 37. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH
    Can Fam Physician; 1993 Jan; 39():119-20, 123-6. PubMed ID: 8435549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
    Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
    Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.
    Ashworth M; Lloyd D; Smith RS; Wagner A; Rowlands G
    J Public Health (Oxf); 2007 Mar; 29(1):40-7. PubMed ID: 17071815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.